Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Weiser

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|April 12, 2002
AMPA receptor antagonists with additional mechanisms of action: new opportunities for neuroprotective drugs?Thomas Weiser
Journal of Neuroscience Methods|June 16, 2004
A novel toxicity-based assay for the identification of modulators of voltage-gated Na+ channelsThomas Weiser
CNS Neuroscience & Therapeutics|May 17, 2008
Ambroxol: a CNS drug?Thomas Weiser
Current Drug Targets. CNS and Neurological Disorders|April 29, 2005
AMPA receptor antagonists for the treatment of strokeThomas Weiser
Neuroscience Letters|November 19, 2005
Comparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1.2 channelsThomas Weiser
Medizinische Monatsschrift Fur Pharmazeuten|November 6, 2004
[Local anesthetics and pain therapy in pharyngitis]Horst Wunderer, Thomas Weiser
Neuroscience Letters|December 17, 2008
Hyoscine butylbromide potently blocks human nicotinic acetylcholine receptors in SH-SY5Y cellsThomas Weiser, Stefan Just
Molecular Pharmacology|August 16, 2002
Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxolThomas Weiser, Nicola Wilson
Advances in Therapy|February 14, 2019
Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I StudyThomas Weiser, Harald Weigmann
Phytotherapy Research : PTR|September 11, 2012
Comparison of the effects of pelargonic acid vanillylamide and capsaicin on human vanilloid receptorsThomas Weiser, Basil Roufogalis, Sigrun Chrubasik
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|April 12, 2002
AMPA receptor antagonists with additional mechanisms of action: new opportunities for neuroprotective drugs?Thomas Weiser
Journal of Neuroscience Methods|June 16, 2004
A novel toxicity-based assay for the identification of modulators of voltage-gated Na+ channelsThomas Weiser
CNS Neuroscience & Therapeutics|May 17, 2008
Ambroxol: a CNS drug?Thomas Weiser
Current Drug Targets. CNS and Neurological Disorders|April 29, 2005
AMPA receptor antagonists for the treatment of strokeThomas Weiser
Neuroscience Letters|November 19, 2005
Comparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1.2 channelsThomas Weiser
Medizinische Monatsschrift Fur Pharmazeuten|November 6, 2004
[Local anesthetics and pain therapy in pharyngitis]Horst Wunderer, Thomas Weiser
Neuroscience Letters|December 17, 2008
Hyoscine butylbromide potently blocks human nicotinic acetylcholine receptors in SH-SY5Y cellsThomas Weiser, Stefan Just
Molecular Pharmacology|August 16, 2002
Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxolThomas Weiser, Nicola Wilson
Advances in Therapy|February 14, 2019
Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I StudyThomas Weiser, Harald Weigmann
Phytotherapy Research : PTR|September 11, 2012
Comparison of the effects of pelargonic acid vanillylamide and capsaicin on human vanilloid receptorsThomas Weiser, Basil Roufogalis, Sigrun Chrubasik
Pageof 7